IoT can help to reduce the burden of clinical trials on patients

Analyst Comment IoT helps to decentralise clinical trials, allowing them to become increasinglypatient-centric and diverse while providing pharmaceutical companies with a higherreturn on investment. Strategic Intelligence April 3, 2025 Clinical trials often place a significant burden on participants, necessitating regular travel to medical facilities, financial obligations, and time away from work, all while participants grapple with the uncertainty of whether they have received an experimental treatment. These challenges can be particularly difficult for specific demographics that are traditionally underrepresented in trials, such as the elderly, children, and individuals who may be cognitively or physically impaired.Addressing these issues benefits not only patients but also the pharmaceutical companies by reducing dropout rates and enhancing the patient experience. These improvements result in decreased recruitment costs and associated delays. Additionally, increased accessibility e...